These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

915 related articles for article (PubMed ID: 7902432)

  • 1. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys.
    Gasior M; Paronis CA; Bergman J
    J Pharmacol Exp Ther; 2004 Jan; 308(1):249-59. PubMed ID: 14563783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of the discriminative-stimulus effects of GBR 12909.
    Melia KF; Spealman RD
    J Pharmacol Exp Ther; 1991 Aug; 258(2):626-32. PubMed ID: 1678014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes.
    Spealman RD; Bergman J; Madras BK; Melia KF
    J Pharmacol Exp Ther; 1991 Sep; 258(3):945-53. PubMed ID: 1679852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
    Jutkiewicz EM; Bergman J
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of D1 and D2 dopamine receptor antagonists in squirrel monkeys.
    Bergman J; Madras BK; Spealman RD
    J Pharmacol Exp Ther; 1991 Sep; 258(3):910-7. PubMed ID: 1890625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections.
    Witkin JM; Nichols DE; Terry P; Katz JL
    J Pharmacol Exp Ther; 1991 May; 257(2):706-13. PubMed ID: 1674533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
    Kamien JB; Goldberg LI; Woolverton WL
    J Pharmacol Exp Ther; 1987 Sep; 242(3):804-11. PubMed ID: 2958620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1039-46. PubMed ID: 8099614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
    Filip M; Przegaliński E
    Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF; Sheng J
    J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
    Platt DM; Rowlett JK; Spealman RD
    J Pharmacol Exp Ther; 2000 Jun; 293(3):1017-26. PubMed ID: 10869406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA; Widzowski DV; Newland MC
    J Pharmacol Exp Ther; 1989 Sep; 250(3):800-8. PubMed ID: 2789282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine D(1) receptor agonist SKF-82958 serves as a discriminative stimulus in the rat.
    Haile CN; Carey G; Varty GB; Coffin VL
    Eur J Pharmacol; 2000 Jan; 388(2):125-31. PubMed ID: 10666503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
    Katz JL; Kopajtic TA; Myers KA; Mitkus RJ; Chider M
    J Pharmacol Exp Ther; 1999 Oct; 291(1):265-79. PubMed ID: 10490913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine.
    Terry P; Witkin JM; Katz JL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1041-8. PubMed ID: 7932151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys.
    Bergman J; Rosenzweig-Lipson S; Spealman RD
    J Pharmacol Exp Ther; 1995 Apr; 273(1):40-8. PubMed ID: 7714795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.